Anti-ARL4D Antibody

ARL4D antibody

Boster Bio Anti-ARL4D Antibody catalog # A11217. Tested in WB applications. This antibody reacts with Human, Mouse, Rat.

Product Info Summary

SKU: A11217
Size: 100 μl/vial
Reactive Species: Human, Mouse, Rat
Host: Rabbit
Application: WB

Customers Who Bought This Also Bought

Product Name

Anti-ARL4D Antibody

View all ARL4D Antibodies

SKU/Catalog Number

A11217

Size

100 μl/vial

Form

Liquid

Description

Boster Bio Anti-ARL4D Antibody catalog # A11217. Tested in WB applications. This antibody reacts with Human, Mouse, Rat.

Storage & Handling

12 months from date of receipt,-20℃ as supplied. 6 months 2 to 8℃ after reconstitution. Avoid repeated freezing and thawing.

Cite This Product

Anti-ARL4D Antibody (Boster Biological Technology, Pleasanton CA, USA, Catalog # A11217)

Host

Rabbit

Contents

500 μg/ml antibody with PBS, 0.02% NaN3, 1 mg stabilizing protein and 50% glycerol
This antibody is supplied in a stabilized formulation.
Compatibility with conjugation reactions depends on the chemistry of the conjugation method used.
For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.

Clonality

Polyclonal

Immunogen

E.coli-derived human ARL4D recombinant protein (Position: N3-K198).

Reactive Species

A11217 is reactive to ARL4D in Human, Mouse, Rat

Calculated molecular weight

22.2 kDa

Background of ARL4D

ADP-ribosylation factor 4D is a member of the ADP-ribosylation factor family of GTP-binding proteins. ARL4D is closely similar to ARL4A and ARL4C and each has a nuclear localization signal and an unusually high guanine nucleotide exchange rate. This protein may play a role in membrane-associated intracellular trafficking.

Antibody Validation

Boster validates all antibodies on WB, IHC, ICC, Immunofluorescence, and ELISA with known positive control and negative samples to ensure specificity and high affinity, including thorough antibody incubations.

View more details

Applications

A11217 is guaranteed for WB Boster Guarantee

Assay Dilutions Recommendation

The recommendations below provide a starting point for assay optimization. The actual working concentration varies and should be decided by the user.

Western blot, 1:500-2000

Validation Images & Assay Conditions

There are currently no images for this product. We are working on uploading them please check back shortly or contact us to expedite our upload process for this antibody.

Loading publications

No publications found

Do you have publications using this product? Share with us and receive a reward. Contact us for more information.

Publications not available. Please try again later.

Product has been cited in publications

No results found matching your query

  • Published: --- Journal: --- Application: --- Impact Factor: --- Species: --- PMID: --- View Article

Have you used Anti-ARL4D Antibody?

Share your experimental results or join a short interview to earn up to $1,000 in product credits or other rewards.

0 Reviews For Anti-ARL4D Antibody

Have a question?

Find answers in Q&As, reviews.

Can't find your answer?

Submit your question

0 Customer Q&As for Anti-ARL4D Antibody

Order DetailsPrice
A11217

100 μL

$370

Free Secondary Antibody

FREE  $95.00
FREE  $95.00
$40.00  $80.00
$75.00  $150.00
$30.00  $60.00
$75.00  $150.00
$65.00  $130.00
$55.00  $110.00
$67.50  $135.00
Choose an option to show lead time.
Get A Quote
In stock
Order Product
A11217
Buy one primary antibody get one 0.5ml HRP or Biotin secondary antibody for free.
*Sample sizes are prepared on demand and will take extra lead time. (cannot be conjugated)
$370.00

Troubleshooting

troubleshooting-box-image

Download troubleshooting handbooks for IHC, Western blot and ELISA for FREE.

Download Free PDFs Now

Boster Guarantee

Guaranteed product quality

Guaranteed product quality

We promise all of our products perform as described in datasheets.

This product is for Research Use Only. Not for use in diagnostic procedures.

Update date: May 1, 2026